Clinical Trial Update: F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)

View source ↗

Summary

This clinical trial update reports that the study evaluating F-18-AV-45 imaging uptake and spot sign in cerebral amyloid angiopathy-related intracranial hemorrh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Amyloid Angiopathy

Drugs mentioned

• Florbetapir F-18 (florbetapir F-18)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Cerebral Amyloid Angiopathy | Status: WITHDRAWN